Related Experiment Video
Updated: Jun 24, 2026
19:32
Preterm EEG: A Multimodal Neurophysiological Protocol
Published on: February 18, 2012
Controversies in neonatal seizure management
Hannah C Glass1, Elaine Wirrell
1Departments of Neurology and Pediatrics, University of California, San Francisco, USA. Hannah.Glass@ucsf.edu
Journal of Child Neurology
|February 17, 2009
Summary
Neonatal seizures are common and signal brain injury. This review addresses the lack of evidence-based guidelines for defining, monitoring, and treating these seizures in newborns.
Area of Science:
- Neonatology
- Pediatric Neurology
- Neuroscience
Background:
- Neonatal seizures are frequent and often indicate severe brain injury in newborns.
- Evidence suggests neonatal seizures can negatively impact brain development.
- Current clinical practice lacks evidence-based guidelines for managing neonatal seizures.
Purpose of the Study:
- To review current controversies in the evaluation and management of neonatal seizures.
- To discuss the definition, monitoring, and treatment of seizures in newborns.
- To inform child neurologists and neonatologists on best practices for neonatal seizures.
Main Methods:
- Literature review of existing studies on neonatal seizures.
- Analysis of current evidence regarding seizure definition and diagnosis.
- Discussion of therapeutic strategies and monitoring techniques for neonatal seizures.
Main Results:
- Significant controversies exist regarding the definition and diagnosis of neonatal seizures.
- There is a lack of consensus on optimal monitoring and treatment protocols.
- Existing evidence highlights potential long-term neurodevelopmental consequences.
Conclusions:
- There is an urgent need for evidence-based guidelines for neonatal seizure management.
- Standardizing the definition, monitoring, and treatment of neonatal seizures is crucial.
- Addressing these controversies will improve neurodevelopmental outcomes for affected infants.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:08Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:19Seizures ll: Types
Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...